(Q30051169)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Status of vaccine research and development of vaccines for GBS (English)

2 references

25 May 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1

Paul T. Heath

1 reference

25 May 2017

language of work or name

English

0 references

publication date

15 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

2 references

25 May 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

34

2 references

25 May 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

26

2 references

25 May 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

2876-2879

2 references

25 May 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Invasive group B streptococcal infection in infants, Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

High burden of invasive Streptococcus agalactiae disease in South African infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Variation in reported neonatal group B streptococcal disease incidence in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Carriage of group B streptococcus in pregnant women from Oxford, UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Rapid detection of group B streptococci in pregnant women at delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Group B streptococcal disease in infants: a case control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Long-term outcomes of group B streptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Meningitis in infancy in England and Wales: follow up at age 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Maternal group B Streptococcus-related stillbirth: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Effectiveness of maternal pertussis vaccination in England: an observational study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Introduction of a conjugate meningococcal type C vaccine programme in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

An update on vaccination against group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.072

10.1016/J.VACCINE.2015.12.072

7 January 2021

Identifiers

DOI

3 references

25 May 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988258%20AND%20SRC:MED&resulttype=core&format=json

release_omzk4oj7ffarbdonp4v3gekjga

11 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/omzk4oj7ffarbdonp4v3gekjga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017